924 material Form 8-K filings that 737 companies we cover made with the SEC in January 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Lafayette Digital Acquisition Corp. I, a Cayman Islands blank check company, closed its initial public offering on January 12, 2026, selling 28,750,000 units at $10.00 each for gross proceeds of $287.5 million, including the full exercise of the underwriters' over-allotment option. The filing says the net proceeds, including $10,062,500 in deferred underwriting commissions, were placed in a trust account for public shareholders, and the company intends to use the proceeds to pursue a business combination with one or more businesses.
IPO closed January 12, 2026: 28,750,000 units at $10.00 per unit, including 3,750,000 over-allotment units, for gross proceeds of $287,500,000.
Each unit includes one Class A ordinary share and one-fourth of one redeemable warrant exercisable at $11.50 per share.
Private placement of 760,000 units for $7,600,000 to the Sponsor (435,000 units) and BTIG, LLC (325,000 units).
Jason Glazer and Robert Cusack were appointed to the board on January 8, 2026; the amended and restated articles were adopted in connection with the IPO.
Amphastar entered into an exclusive license agreement with Nanjing Hanxin Pharmaceutical Technology on January 6, 2026, for AMP-110, a fully synthetic corticotropin compound in early-phase human clinical development, covering the United States and Canada. Hanxin is controlled by family members of Amphastar's CEO and Chairman, so the agreement and two related amendments are related party transactions, and the company says the amendments are not expected to be material.
Amphastar made a $2 million upfront payment to Hanxin, with up to $14 million in development milestones and up to $75 million in sales milestones.
Royalties payable by Amphastar to Hanxin are capped at $7.5 million per calendar year and $60 million in total accumulated.
Dr. Jack Zhang and Dr. Mary Luo and certain family members own a majority of Hanxin; the Audit Committee approved the distribution and manufacturing amendments.
The Distribution and Manufacturing Amendments expand territories; their value is not determinable until sales occur in the expanded regions.
Arrowhead Pharmaceuticals issued $700 million of 0.00% convertible senior notes due January 15, 2032, including $75 million from the underwriters' full exercise of their over-allotment option. The company also spent approximately $47.9 million on capped call transactions, which are expected to reduce potential dilution from future conversions of the notes.
Notes issued January 12, 2026: $700 million principal, 0.00% interest rate, maturing January 15, 2032
Initial conversion price of approximately $87.07 per share; the company may settle conversions in cash, shares or a combination
Capped call transactions cost approximately $47.9 million, with a cap price of approximately $119.33 per share
Company may redeem notes on or after January 16, 2029 if the stock exceeds 130% of the conversion price under specified conditions
Moody's Corporation named Lisa P. Sawicki, former Chair of the Global Board at PricewaterhouseCoopers, as a director effective March 16, 2026, expanding the board to ten members. She will also join the Audit and Governance & Nominating committees.
Election effective March 16, 2026; board grows to ten directors
Annual cash retainer of $120,000, paid quarterly
Annual restricted stock unit award equivalent in value to $230,000, vesting on the first anniversary of grant
Sawicki served as Chair of the Global Board at PwC from 2021 to 2025
EOG Resources filed an 8-K under Item 2.02 that covers its price risk management for the fourth quarter of 2025. The excerpt shows EOG paid a net $21 million to settle financial commodity derivative contracts, and it reports average Q4 2025 benchmark prices. The excerpt does not include revenue, profit, EPS or guidance, so it does not show whether results improved or declined.
Net cash paid for settlements of financial commodity derivative contracts in Q4 2025: $21 million
Q4 2025 NYMEX West Texas Intermediate crude averaged $59.17 per barrel; Henry Hub natural gas averaged $3.55 per million British thermal units
No cash received under the 10-year Brent Linked Gas Sales Contract; deliveries are expected to start in January 2027
Quest Diagnostics filed a presentation from its January 12, 2026 appearance at the 44th Annual J.P. Morgan Healthcare Conference, where Chairman, CEO and President Jim Davis discussed strategy and market trends. The filing contains no new quarterly results, but it restates a long-term outlook for revenue, adjusted EPS and capital deployment through 2027.
Long-term outlook beyond 2025: 4% to 5% revenue CAGR and 7% to 9% adjusted EPS CAGR, with operating margins up 75 to 150 basis points by the end of 2027.
Targeted capital deployment for 2025 to 2027 includes $4.5 billion to $5.0 billion in operating cash flow and $3.0 billion to $3.3 billion in free cash flow.
Planned uses include about $1.5 billion for acquisitions, about $1.0 billion for dividends and about $0.7 billion for share repurchases.
The presentation says the capital deployment plan is consistent with what the company shared at its March 2025 Investor Day.
T-Mobile USA, a wholly-owned subsidiary of T-Mobile US, closed an underwritten public offering of $1.15 billion of 5.000% senior notes due 2036 and $850 million of 5.850% senior notes due 2056 on January 12, 2026. Net proceeds are expected to refinance existing indebtedness on an ongoing basis or for general corporate purposes, and the notes are guaranteed on a senior unsecured basis by the parent and certain subsidiaries.
2036 Notes: $1.15 billion principal at a 5.000% coupon
2056 Notes: $850 million principal at a 5.850% coupon
Offering closed January 12, 2026, under an underwriting agreement dated January 7, 2026
Proceeds expected for refinancing existing debt or general corporate purposes
Artisan Partners reported preliminary assets under management of $179.9 billion as of December 31, 2025, in a press release filed with the 8-K. The filing also says the board added Clarence Kane Brenan as a director on January 9, 2026, expanding it from eight to nine members, and that a subsidiary closed its acquisition of Grandview Property Partners, LLC on January 2, 2026.
Total firm AUM was $179.9 billion as of December 31, 2025, including $87.8 billion in Artisan Funds and Artisan Global Funds and $92.1 billion in separate accounts and other AUM.
December month-end AUM includes the impact of approximately $640 million of Artisan Funds distributions that were not reinvested.
Clarence Kane Brenan, former CEO of TIFF Investment Management, was appointed to the board on January 9, 2026 and to the Compensation Committee.
A subsidiary closed its previously announced acquisition of 100% of the equity of Grandview Property Partners, LLC on January 2, 2026.
Chipotle said two executives, Chief Legal Officer Roger Theodoredis and President and Chief Brand Officer Chris Brandt, have transitioned out of their executive roles effective January 12, 2026, and will stay on in advisory roles for a limited period. Chief Human Resources Officer Ilene Eskenazi takes on the combined chief legal and human resources role, and Stephanie Perdue is interim Chief Marketing Officer while the company searches for a permanent CMO. The company also reaffirmed its full-year 2025 guidance issued in October, which keeps its prior financial outlook unchanged.
Ilene Eskenazi appointed Chief Legal and Human Resources Officer, effective immediately, succeeding Roger Theodoredis
Stephanie Perdue, Vice President of Brand Marketing, named interim Chief Marketing Officer, succeeding Chris Brandt
Company reaffirmed full-year 2025 financial guidance issued in October 2025
Fourth quarter and fiscal year 2025 earnings call scheduled for February 3, 2026
Crescent Energy said it expects to report about $165 million of total cash received from hedge positions for the full year 2025 and about $84 million for the fourth quarter, based on preliminary figures. The company says the amounts are subject to change and final results will appear in its 2025 Form 10-K.
Full-year 2025 total cash received from hedges: approximately $165 million
Three months ended December 31, 2025 total cash received from hedges: approximately $84 million
Settlements of derivatives acquired in the SilverBow and Vital mergers contributed $83 million for the year and $34 million for the quarter
Final amounts to be reported in the 10-K for the year ended December 31, 2025
Regions Financial said Chief Financial Officer David Turner will retire effective March 31, 2026, and Anil Chadha, currently Controller and head of Corporate Finance, will succeed him as Senior Executive Vice President, Chief Financial Officer. A CFO change is a significant leadership transition, and the filing says the two will work together through March to ensure a smooth handoff, while Chadha's compensation terms have not yet been disclosed.
David J. Turner, Jr. retires as CFO effective March 31, 2026, after about 40 years in auditing and finance, including 20 years at the bank
Anil D. Chadha, 47, becomes CFO upon Turner's retirement; he has been Controller since December 2021 and head of Corporate Finance since December 2023
Regions says material compensation terms for both executives will be disclosed once approved
NetApp's board increased its size from nine to ten authorized directors and appointed Paul Fipps, President of Global Customer Operations at ServiceNow, to fill the new seat, effective with the January 8, 2026 board action. The company said nine of the ten directors are independent, and Fipps will join the non-employee director compensation program. The filing contains no financial results or guidance, so the appointment is a governance change rather than a change to the company's financial outlook.
Board approved on January 8, 2026 to increase authorized directors from nine to ten and appointed Paul Fipps to fill the vacancy.
Fipps is President of Global Customer Operations at ServiceNow, previously EVP of Worldwide Sales at ServiceNow and President of Under Armour Connected Fitness.
NetApp says nine of its ten directors are independent and 50% were appointed within the last five years.
Fipps will receive compensation under the non-employee director program and is expected to sign the standard indemnification agreement.
On January 12, 2026, Sonos increased its Board from eight to ten members and appointed Carmine Arabia, Mandy Fields and Joe Kennedy as directors, effective immediately. The filing discloses no committee roles, and the Board determined all three are independent under Nasdaq standards, so the change adds board capacity rather than altering management.
Board expanded from eight to ten members; Arabia (Class II, term to 2026 annual meeting), Fields (Class III, to 2027) and Kennedy (Class I, to 2028) appointed effective immediately
No committee appointments made at this time
Each new director is to receive standard non-employee director compensation and a standard indemnification agreement
Arabia is VP of Devices at Meta; Fields is CFO of e.l.f. Beauty; Kennedy is a former Pandora CEO and President
Verizon's Human Resources Committee approved an amendment to a letter agreement with CEO Daniel H. Schulman that sets updated terms for a $30 million target value performance stock unit award. The award, which vests on December 31, 2027 if earned, ties half its value to adjusted earnings per share targets and half to relative total shareholder return.
Committee approved the amendment on January 8, 2026, to the letter agreement with Daniel H. Schulman dated October 13, 2025
Target value of the PSU award is $30 million, to be granted in the first quarter of 2026 on the annual long-term incentive grant date
50% vests on adjusted EPS targets and 50% on relative total shareholder return, with payouts of 0-200% of target for the TSR portion
Award vests, to the extent earned, on December 31, 2027, generally subject to continued employment
Pool Corporation announced that Kenneth G. St. Romain, Senior Vice President, will retire in 2026 and will stay in his role until later in the year to assist with the transition. The company also said John B. Watwood joined as Executive Vice President effective January 12, 2026, leading North American swimming pool operations and overseeing digital and technology initiatives. The filing contains no financial results, so the change is administrative in nature for shareholders.
Kenneth G. St. Romain, Senior Vice President, will retire in 2026 and has not set a specific retirement date.
John B. Watwood joined as Executive Vice President effective January 12, 2026, reporting to CEO Peter D. Arvan.
Watwood will lead North American swimming pool operations and oversee digital and technology initiatives.
Watwood previously held management roles at Motion Industries, Inc. since 2008, most recently as Senior Vice President of Sales and Operations for the United States and Canada.
Masco entered into an agreement effective January 12, 2026 with former Group President, Decorative Architectural Products Imran Ahmad, whose service ended December 31, 2025. The agreement sets out a $998,875 cash payment plus conditional payments tied to 2025 bonus and 2023-2025 LTIP performance goals, and a 90-day window to exercise vested options and stock appreciation rights.
Cash payment of $998,875 to Imran Ahmad
2025 cash bonus and 2023-2025 LTIP cash payment are conditional on established performance goals being met
Cash equivalent of an annual restricted stock unit award based on his individual target opportunity
Vested stock options and SARs exercisable for 90 days after service ended December 31, 2025
CAVA Group announced that Douglas W. Thompson will become its Chief Operations Officer effective March 2, 2026, overseeing restaurant operations and field teams and reporting to CEO Brett Schulman. The filing sets out his compensation, including a $550,000 base salary, a target cash bonus of 75% of base salary, and a $200,000 relocation and sign-on bonus, which adds a new operations executive and the associated pay terms for shareholders to note.
Thompson, 62, becomes Chief Operations Officer effective March 2, 2026 and reports directly to CEO Brett Schulman.
Offer letter provides a $550,000 annual base salary and a target cash bonus of 75% of base salary.
Equity award with approximate grant date value of $1,200,000 expected from fiscal 2027, plus a one-time restricted stock unit grant of approximately $500,000 and a $200,000 sign-on bonus.
Thompson was CEO of Tumble 22 Texas Chicken Joint from October 2022 and served as COO of Texas Roadhouse from August 2018 to December 2021.
Tanger's operating partnership issued $250 million of 2.375% exchangeable senior notes due January 15, 2031, including a $30 million option exercise. Net proceeds were about $243 million, which the company plans to use to repay a $350 million 3.125% note maturing September 1, 2026, repay credit line debt, and for general corporate purposes. The notes can be exchanged for Tanger common shares at an initial price of about $41.55, a 22.5% premium over the January 7, 2026 closing price of $33.92.
Notes: $250 million principal at 2.375% interest, maturing January 15, 2031, including $30 million from full exercise of the initial purchasers' option.
Net proceeds of about $243 million; about $20 million used to repurchase roughly 0.6 million common shares at $33.92 and about $9 million used for capped call transactions.
Planned use: repay the $350 million 3.125% senior notes due September 1, 2026, and outstanding unsecured line of credit debt.
Initial exchange price of about $41.55 per share; the notes are guaranteed by Tanger Inc. on a senior unsecured basis.
Alexandria Real Estate amended the 2025 long-term incentive grant for Executive Chairman Joel S. Marcus, so 100% of the grant now vests only on corporate performance criteria, with no time-based vesting. The filing says the target value stays at $3.6 million, while the maximum value rises to $5.4 million from $4.5 million under the prior terms. The company also elected John Hart Cole as Co-President and Co-Regional Market Director for Seattle, effective January 1, 2026.
Marcus's 2025 LTI grant, made January 9, 2026, keeps a $3.6 million target value, now fully performance-based.
Maximum value of the 2025 grant rises to $5.4 million, or 150% of the target, from a prior combined maximum of $4.5 million.
The amendment applies only to the 2025 grant and not to later grants or other awards to Marcus.
John Hart Cole was elected Co-President effective January 1, 2026; his only contemplated pay change is a base salary increase, with no amount disclosed.
Diamondback Energy disclosed fourth-quarter 2025 realized prices, derivative results and weighted average share counts in an Item 2.02 filing. The filing does not include revenue, net income, earnings per share or guidance, so shareholders cannot assess overall profitability from it.
Average unhedged realized oil price was $58.00 per barrel; hedged oil price was $57.07 per barrel.
Average unhedged natural gas price was $0.03 per Mcf and hedged price was $1.03 per Mcf; NGL price was $13.51 per barrel.
Expected total gain on derivative instruments was $192 million, including a $73 million net cash gain on settlements.
Basic and diluted weighted average shares outstanding were 285,789 thousand for the quarter.
Flanigan's Enterprises announced a broad leadership reshuffle, with James G. Flanigan II stepping down as President and Chairman, and Jeffrey D. Kastner stepping down as CFO to become Chairman and Chief Legal Officer. Allison Govoni becomes CFO and Peter Bruce becomes COO, both internal promotions, which shareholders may view as a significant change in top management.
James G. Flanigan II resigned as President and Chairman effective January 8, 2026, and remains CEO and a Board member
Jeffrey D. Kastner resigned as CFO effective January 8, 2026, and was named Chief Legal Officer and Chairman of the Board
Christopher O'Neil was named President effective January 8, 2026, with an annual base salary of $464,000
Allison Govoni named CFO effective January 8, 2026, at $222,000 annual base salary; Peter Bruce named COO at $272,000
Bristol-Myers Squibb furnished an investor presentation from its 44th Annual J.P. Morgan Healthcare Conference, posted to its website on January 12, 2026. The deck covers Growth Portfolio sales, pipeline timelines, and capital returns, but it reports no new quarterly results or guidance changes.
Growth Portfolio sales rose 17% for the nine months ended 9/30/25 versus the same period in 2024
About $14.5 billion in dividends and about $8 billion in share repurchases over the past three years, per the presentation
Company cites 94 consecutive years of dividend payments; latest dividend declared 12/10/2025 and payable 2/2/2026
Concentra published a presentation for the J.P. Morgan Healthcare Conference, to be given January 14, 2026, with preliminary, unaudited Q4 2025 operational metrics. The filing shows early visits-per-day growth but no revenue, profit or earnings per share figures for the quarter, which the company says will come in late January.
Early look shows Q4 2025 visits per day up year over year at +3.4%, +9.1%, +2.3% and +9.4% across total company (excluding Nova), workers' compensation and employer services.
Concentra repurchased about 1.1 million shares in Q4 2025.
Late January: Q4 and FY 2025 flash results and 2026 guidance; regularly scheduled Q4 earnings call in late February.
Presentation lists FY 2025 guidance of $2.145 billion to $2.160 billion in revenue and $425 million to $430 million in Adjusted EBITDA.
Zimmer Biomet said Mark Bezjak, a named executive officer in its 2025 proxy statement, informed the company on January 8, 2026 that he will resign his employment and all officer positions effective January 16, 2026, to pursue another business opportunity. The filing notes he already ceased to be an executive officer on July 1, 2025, so the change is largely a formal exit. The filing does not name a successor.
Mark Bezjak notified the company on January 8, 2026 of his resignation.
Resignation takes effect January 16, 2026, covering his employment and all officer roles at the company and its affiliates.
Bezjak stopped being an executive officer on July 1, 2025, as previously reported.
The filing reports no financial results; its only exhibit is the Inline XBRL cover page file.
Osprey Funds, LLC, the sponsor of Osprey Bitcoin Trust, and Delaware Trust Company signed an amendment on January 9, 2026 to the trust agreement. The change moves the cutoff for cash purchase and redemption orders from 6:00 p.m. to 5:30 p.m. Eastern Time on the business day before the trade date. The filing describes this as an administrative update to order timing, and it does not mention any change to fees, assets or share economics.
Amendment dated January 9, 2026, between Osprey Funds, LLC and Delaware Trust Company
Cash purchase and redemption order cutoff moved from 6:00 p.m. to 5:30 p.m. Eastern Time on the prior business day
Full amendment filed as Exhibit 1.01 to the 8-K; report signed January 12, 2026 by CEO Gregory D. King
MACOM Technology Solutions appointed Bryan Ingram as an independent director effective January 12, 2026, to serve until the 2026 annual meeting. Ingram previously led Broadcom's Wireless Semiconductor Division and served as chief operating officer at Avago Technologies, and the company said he has managed semiconductor businesses with more than $4 billion in revenue. The filing is a board appointment with no financial results or guidance included.
Bryan Ingram appointed to the board effective January 12, 2026, to hold office until the 2026 annual meeting of stockholders
Board determined Ingram is independent under Nasdaq listing rules and SEC rules
Ingram previously served as SVP and General Manager of Broadcom's Wireless Semiconductor Division (November 2015 to October 2019) and as COO of Avago Technologies (April 2013 to October 2015)
Ingram will receive compensation under the company's non-employee director program and has entered into the standard indemnification agreement
Allegiant agreed on January 11, 2026 to merge with Sun Country Airlines, with Sun Country becoming a wholly owned subsidiary. Sun Country holders would receive $4.10 in cash and 0.1557 Allegiant shares per share, and the companies say the deal values Sun Country at about $1.5 billion including $0.4 billion of net debt. The deal requires stockholder, regulatory and other approvals and is expected to close in the second half of 2026, with Allegiant shareholders owning about 67% of the combined company.
Sun Country holders would receive $4.10 in cash plus 0.1557 Allegiant shares per share, an implied $18.89 per share, a 19.8% premium to the $15.77 closing price on January 9, 2026.
Allegiant shareholders would own about 67% of the combined company and Sun Country shareholders about 33%, on a fully diluted basis.
Allegiant expects $140 million in annual synergies within three years of closing and says the deal should be accretive to earnings per share one year after closing.
Termination fees range from $30 million to $52.23 million depending on the circumstances, and the agreement can be terminated if the merger is not completed by January 11, 2027.
TransMedics entered a lease on January 8, 2026 for about 498,286 square feet at 188 Assembly Park Drive in Somerville, Massachusetts, to serve as its new headquarters beginning on or before January 1, 2028, replacing its Andover site. The filing also discloses initial annual base rent of about $23.9 million, an $18 million letter of credit security deposit, and the purchase of two adjacent parcels for $15.0 million each.
Lease covers about 498,286 square feet; base rent initially about $23.9 million per year, rising 2% annually
Lease initial term is 192 months from the Rent Commencement Date, with two ten-year extension options
Security deposit delivered as a letter of credit of about $18 million
On January 8, 2026, the company bought two adjacent Somerville parcels for $15.0 million each, plus related costs
Alkermes furnished a corporate presentation for the J.P. Morgan Healthcare Conference that includes preliminary, unaudited estimated total revenues for 2025. The filing says these figures may change after the company completes its year-end financial statement review, and it gives no prior-year comparison or profit figures.
Presentation states the commercial business generated total revenues above $1.45 billion in 2025.
Revenue figures are preliminary and unaudited and subject to change after the year-end review.
Presentation was made available January 12, 2026, for a J.P. Morgan Healthcare Conference presentation on January 13, 2026.
The planned Avadel acquisition is expected to close in Q1 2026.
Krystal Biotech disclosed preliminary, unaudited 2025 results ahead of its J.P. Morgan Healthcare Conference presentation on January 12, 2026, including VYJUVEK net product revenue and cash of about $955 million as of December 31, 2025. It also gave 2026 combined non-GAAP R&D and SG&A expense guidance of $175 million to $195 million. The company said its audit is ongoing and the figures could change, with full 2025 results due in February 2026.
Preliminary Q4 2025 VYJUVEK net product revenue of $106 million to $107 million; full year 2025 of $388 million to $389 million
Cash, cash equivalents and investments of approximately $955 million as of December 31, 2025
2026 combined non-GAAP R&D and SG&A expense guidance of $175 million to $195 million, excluding stock-based compensation
Figures are unaudited and subject to change; full 2025 results to be reported in February 2026
FIS completed its acquisition of Global Payments' Issuer Solutions business on January 9, 2026, paying approximately $7.7 billion in cash and exchanging its Worldpay stake for the business. The company says the deal adds a credit issuing processing business and expects it to add $500 million in incremental Adjusted Free Cash Flow in 2026 and $700 million by 2028, though the filing includes no reported financial results for the acquired business.
Closed January 9, 2026; FIS paid approximately $7.7 billion in cash, subject to customary post-closing adjustments.
Issuer Solutions valued at a $13.5 billion enterprise value; Worldpay valued at a $24.25 billion enterprise value.
FIS expects an additional $500 million in Adjusted Free Cash Flow in 2026 and $700 million by 2028.
Financial statements for the acquired business and pro forma information will be filed by amendment within 71 calendar days.
Global Payments said on January 12, 2026 that it completed its acquisition of Worldpay from FIS and GTCR and sold its Issuer Solutions business to FIS. The filing also issued stock to GTCR, which now holds approximately 15.45% of Global Payments common stock, and set lock-up, standstill and registration terms for those shares. Shareholders face a larger share count and a new ownership stake, and the company said it expects to reduce adjusted net leverage to 3.0x within 18 to 24 months.
Acquisition of Worldpay and divestiture of Issuer Solutions to FIS completed, announced January 12, 2026
Stock Consideration issued to GTCR on January 9, 2026; GTCR now holds approximately 15.45% of outstanding common stock
Lock-up: 35% of GTCR's shares released 12 months after closing, 15% at 15 months, remainder at 18 months
Company expects to reduce adjusted net leverage to 3.0x within 18 to 24 months and plans to invest over $1 billion annually
Uber said that starting in the first quarter of 2026 it will report Non-GAAP Operating Income, Non-GAAP Net Income and Non-GAAP EPS in place of Adjusted EBITDA, and will switch its segment performance measure to Segment Operating Income. The filing says the change does not restate previously reported GAAP revenue, income from operations, net income or EPS, so it changes how results are presented rather than the reported results themselves.
Non-GAAP Operating Income for the quarter ended September 30, 2025 was $1,675 million, compared with GAAP income from operations of $1,113 million.
Non-GAAP EPS for the quarter ended September 30, 2025 was $0.65, compared with GAAP diluted EPS of $3.11.
The new measures take effect in the first quarter of 2026. Interest income will be shown separately starting with the 10-K for the fiscal year ending December 31, 2025.
The filing provides recast figures for the seven quarters ended September 30, 2025.
Henry Schein appointed Frederick M. Lowery, currently Executive Vice President and President of Laboratory Products and BioProduction at Thermo Fisher Scientific, as chief executive officer effective March 2, 2026, and expanded its board from 14 to 15 members to seat him. Current CEO Stanley M. Bergman will remain CEO until Lowery starts, then become Chairman of the Board. The filing also amends the company's bylaws to remove the requirement that the board appoint a President.
Lowery's employment agreement sets a base salary of $1,250,000 and a target annual bonus of no less than 150% of base salary for 2026.
Lowery will receive a 2026 equity award with a target grant date fair value of $10,000,000, plus a $2,500,000 sign-on equity award vesting over three years.
Bergman continues as CEO until Lowery begins work, then becomes Chairman of the Board.
The board amended the bylaws effective January 10, 2026, to allow a CEO who is not also President or Chairman.
US Foods reaffirmed the fiscal 2025 guidance it first gave on its November 6, 2025 third quarter earnings call, and the filing reports no new financial results. The company also said CEO Dave Flitman and CFO Dirk Locascio will take part in a fireside chat at the ICR Conference on January 12, 2026, with a webcast available to the public.
Reaffirmed fiscal 2025 guidance: net sales growth of 4% to 5%, Adjusted EBITDA growth of 10% to 12%, and Adjusted Diluted EPS growth of 24% to 26%
Guidance was originally announced on the third quarter earnings call on November 6, 2025
Fireside chat at the 28th Annual ICR Conference in Orlando, Fla., on Monday, January 12, 2026, at 4:30 p.m. EST
Live audio webcast available on the Investor Relations page, with a replay later the same day
WEX said directors Shikhar Ghosh and Jack VanWoerkom will retire from the board at the 2026 Annual Meeting of Stockholders and will not stand for re-election, and that the board will shrink from twelve seats to ten. David Foss, a director since November, will become Vice Chair and Lead Independent Director, and the company said neither retirement stemmed from a disagreement over operations, policies or practices. The filing includes a press release with a preview of fourth-quarter results, but it gives no figures and says only that the company closed the year with a strong quarter.
Ghosh and VanWoerkom retire effective at the 2026 Annual Meeting of Stockholders
Board seats reduced from 12 to 10 effective at the Annual Meeting
David Foss to become Vice Chair and Lead Independent Director; he joined the board in November
Press release previews fourth-quarter results in general terms only, with no specific figures given
Lindsay Corporation appointed Brett R. Coburn as Vice President and Chief Accounting Officer effective January 6, 2026, and stockholders at the same day's annual meeting elected three directors, ratified KPMG LLP as auditor, and approved executive pay on an advisory basis. The filing reports routine governance outcomes and does not disclose financial results.
Brett R. Coburn, 34, was appointed Vice President and Chief Accounting Officer by the Board on January 6, 2026; he previously served as Senior Director, Corporate Controller since February 2024.
Michael N. Christodolou received 7,692,367 votes for and 1,200,426 withheld; Jahidul H. Khandaker received 8,644,185 for; David B. Rayburn received 8,260,227 for.
Stockholders ratified KPMG LLP as auditor for the fiscal year ending August 31, 2026, with 8,720,296 votes for and 597,510 against.
Advisory say-on-pay vote passed with 8,193,803 votes for and 681,543 against; 9,325,331 shares, or 88.0% of 10,591,980 eligible shares, were represented.
Thermo Fisher said Chief Operating Officer Michel Lagarde and Executive Vice President Frederick M. Lowery will leave the company to pursue other opportunities, with departures on March 31, 2026 and February 28, 2026. Effective March 1, 2026, Marc N. Casper becomes Chairman and Chief Executive Officer, and Gianluca Pettiti moves up to President and Chief Operating Officer, a leadership reshuffle that changes who runs the company day to day.
Michel Lagarde, EVP and COO since 2021, departs March 31, 2026
Frederick M. Lowery, EVP since 2024, departs February 28, 2026
Effective March 1, 2026: Marc N. Casper becomes Chairman and CEO
Gianluca Pettiti promoted to President and COO; Michael Shafer takes an expanded role reporting to the CEO
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.